Albright's Board Advisory Practice help Life Science clients build effective boards
DRIVING BOARD EXCELLENCE
Leveraging more than 50 years of experience and Life Sciences industry insights, Albright's Board Evaluation services brings proven approaches to Board Evaluation of Life Sciences organizations - from early start-ups to long time established firms.
We work with boards in the Life Sciences space to design and implement evaluations that promote commitment to healthy board dynamics and continuous improvement.
OUR EVALUATION MARKERS
Our evaluation examine a range of factors impacting board performance: composition, culture, balance of skills & expertise, effectiveness of the board’s decision making processes, organization, quality of debate and strategic input, relationship between the board and management, shareholder communication and accountability, and succession planning processes.
Our Board Evaluation Team helps boards turn evaluations into strategic assets, achieve excellence, and confidently lead their organizations into the future. We provide an expert independent view through our externally facilitated evaluations.
BOARD PRACTICE LEADER
Henrik Brabrand, CEO
Albright Partners A/S
M: +45 7199 2799 I E: email@example.com
Henrik is heading up the Life Sciences Board Practice at Albright Partners A/S. For the past two decades he has conducted Executive Search and Board Search assignments for clients in the Life Sciences industry - globally. Moreover, Henrik has a Board Certificate from Board Assure and a CBS Board Education in Board Work and Corporate Governance for Life Science Startups.
LIFE SCIENCE BOARD OF DIRECTORS GUIDE
Building a strong board seems more complex than ever. Increasing liabilities and duties put on the directors, high-profile board failures, booming activist investing and the disruption of industries and business models – these are just a few reasons why ensuring a strong board of directors is business critical for any company today.
This guide takes a deeper look at the unique requirements posed to the board of directors in the life science industry while answering the question: “What desirable capabilities and experiences should a life science board of director possess?”